Institutional Ownership Igm Biosciences, Inc. (IGMS)
This table provides information about the institutional ownership of Igm Biosciences, Inc. (IGMS). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 928,952 shares, which have been reported (via 13F filing form) to have a value of $1.18 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
883,081
shares
|
$1.12 Million
0.0% of portfolio
|
Q2 2024
Added 16.51%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
45,015
shares
|
$57,169
0.0% of portfolio
|
Q3 2024
Added 10.47%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
400
shares
|
$508
0.0% of portfolio
|
Q2 2025
Added 900.0%
|
|
|
Endurance Wealth Management, Inc.
|
Aug 09, 2023 Q2 2023 |
300
shares
|
$381
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
108
shares
|
$137
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
48
shares
|
$60
0.0% of portfolio
|
Q2 2021
Reduced 94.24%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|